The Australian Medical Research Advisory Board (AMRAB) develops the priorities every 2 years to inform Government decisions on MRFF investments in health and medical research.
AMRAB consulted on the 2020-2022 priorities between 9 September 2020 and 7 October 2020 through our consultation hub and live webinars.
Stakeholders were asked to comment on the appropriateness of the 2018-2020 priorities to guide future MRFF investments under the Australian Medical Research and Innovation Strategy 2016-2021.
AMRAB heard from 270 stakeholders and received more than 250 written submissions.
Read the responses from the public consultation submissions.
/Media Release. View in full here.
